In EMS, how should lipid emulsion therapy be administered to a patient with suspected overdose of a highly lipophilic drug (e.g., bupropion or lamotrigine) causing severe cardiovascular collapse refractory to standard advanced cardiac life support?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 24, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Lipid Emulsion Therapy in EMS for Overdose-Related Cardiovascular Collapse

Direct Answer

Lipid emulsion therapy should NOT be routinely administered in the EMS setting for suspected bupropion or lamotrigine overdose, as current evidence shows it is not first-line therapy for these agents and may actually worsen outcomes when given early after oral ingestion. 1, 2

Critical Context: Lipid Emulsion Is NOT Indicated for Bupropion/Lamotrigine in EMS

Why EMS Should Not Use Lipid Emulsion for These Specific Drugs

  • Bupropion and lamotrigine are sodium channel blockers, NOT local anesthetics, and the evidence for lipid emulsion in sodium channel blocker toxicity is weak and contradictory. 1

  • The American Heart Association explicitly states that lipid emulsion for sodium channel blocker poisoning (including tricyclic antidepressants, which share mechanisms with bupropion) should only be used "if other therapies fail/in last resort" and NOT as first-line therapy. 1

  • Animal studies demonstrate that lipid emulsion given early after oral amitriptyline overdose (a similar sodium channel blocker) significantly DECREASED survival (10% vs 70%, p=0.005) and INCREASED blood drug concentrations, suggesting facilitated gastrointestinal absorption. 2

  • An RCT found no benefit from lipid emulsion administration for hypotension or ECG abnormalities from tricyclic antidepressant poisoning. 1

What EMS SHOULD Do Instead: Sodium Bicarbonate Protocol

First-Line Treatment for Sodium Channel Blocker Overdose

For suspected bupropion or lamotrigine overdose with cardiovascular collapse or QRS prolongation >120 ms, EMS should administer hypertonic sodium bicarbonate (8.4%, 1-2 mEq/kg IV bolus), which has strong evidence for benefit in sodium channel blocker toxicity. 1

Specific EMS Management Algorithm

  1. Secure airway and provide 100% oxygen - hypoxia and acidosis worsen cardiotoxicity. 3

  2. Establish IV access and administer sodium bicarbonate 1-2 mEq/kg (1-2 mL/kg of 8.4% solution) for:

    • QRS prolongation >120 ms 1
    • Wide-complex tachycardia 1
    • Hypotension refractory to fluids 1
    • Cardiac arrest 1

  3. Treat seizures with benzodiazepines (lorazepam 2-4 mg IV or midazolam 5-10 mg IM/IV). 3

  4. For bradycardia, administer atropine 0.5-1 mg IV. 3

  5. Fluid resuscitation with 10-20 mL/kg balanced crystalloid for hypotension. 3

  6. Monitor potassium levels - sodium bicarbonate therapy causes hypokalemia. 1

  7. Rapid transport to facility with ECMO capability for refractory cases. 1

When Lipid Emulsion IS Appropriate in EMS: Local Anesthetic Systemic Toxicity (LAST)

The ONLY Strong Indication for Lipid Emulsion

Lipid emulsion therapy has Class I (strong) evidence ONLY for local anesthetic systemic toxicity (LAST), particularly bupivacaine toxicity, NOT for oral overdoses of medications like bupropion or lamotrigine. 1, 4, 5, 3

LAST Recognition in EMS

  • Suspect LAST when cardiovascular collapse occurs during or immediately after regional anesthesia or nerve block procedures. 3

  • Early signs include circumoral numbness, tinnitus, metallic taste, dizziness, and seizures occurring within minutes of local anesthetic injection. 3

  • Cardiovascular manifestations include bradycardia (often first sign), wide-complex tachycardia, hypotension, and cardiac arrest. 4, 3

Lipid Emulsion Dosing Protocol for LAST (If Applicable)

If LAST is confirmed (not applicable to bupropion/lamotrigine overdose):

  1. Initial bolus: 1.5 mL/kg of 20% lipid emulsion over 1 minute (~100 mL for adults >70 kg). 1, 4, 3

  2. Continuous infusion: 0.25 mL/kg/min immediately after bolus. 1, 4, 3

  3. Repeat bolus once or twice if cardiovascular collapse persists. 3

  4. Continue infusion for 30-60 minutes after hemodynamic stabilization. 3

  5. Use REDUCED-DOSE or AVOID standard 1 mg epinephrine - high-dose epinephrine impairs lipid emulsion effectiveness. 4, 5, 3

Critical Pitfalls to Avoid in EMS

Do NOT Give Lipid Emulsion For:

  • Oral overdoses of any medication - may increase drug absorption from GI tract. 1, 2

  • Sodium channel blocker toxicity (bupropion, lamotrigine, TCAs) - evidence shows harm or no benefit. 1, 2

  • Any overdose where sodium bicarbonate is the established first-line therapy. 1

Complications of Inappropriate Lipid Emulsion Use

  • Severe lipemia interfering with laboratory analysis. 6

  • Hypertriglyceridemia and pancreatitis (reported after 46 mL/kg dose in bupropion overdose). 6

  • Increased drug absorption from GI tract in oral poisonings. 2

  • Decreased survival in animal models of oral sodium channel blocker overdose. 2

Transport Considerations

All patients with suspected bupropion or lamotrigine overdose causing cardiovascular instability should be transported to facilities with:

  • ECMO capability - Class IIb recommendation for refractory sodium channel blocker toxicity. 1

  • Continuous cardiac monitoring and advanced airway management capabilities. 3

  • Medical toxicology consultation availability. 1

Summary of Evidence Quality

The evidence AGAINST lipid emulsion for bupropion/lamotrigine includes:

  • 2023 American Heart Association guidelines explicitly recommend against first-line use for sodium channel blockers. 1

  • Controlled animal study showing 60% absolute mortality increase with lipid emulsion in oral amitriptyline overdose. 2

  • RCT showing no benefit for TCA poisoning. 1

The evidence FOR sodium bicarbonate includes:

  • Class 2a recommendation from American Heart Association for sodium channel blocker toxicity. 1

  • Systematic reviews supporting use in TCA and sodium channel blocker poisoning. 1

  • Decades of clinical experience with favorable outcomes. 1

References

1
Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

3
Guideline

Immediate Management of Local Anesthetic Systemic Toxicity (LAST)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

4
Guideline

Management of ECG Changes in Local Anesthetic Systemic Toxicity (LAST)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

5
Guideline

Management of Local Anesthetic Systemic Toxicity (LAST) Cardiac Arrest

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What are the effects of a Quetiapine (Seroquel) overdose?
Is the ALONE‑AF trial a real study, and does it show that stopping oral anticoagulation is safe in adults (19‑80 years) with non‑valvular atrial fibrillation who are arrhythmia‑free ≥12 months after first catheter ablation and have CHA₂DS₂‑VASc ≥1 (men) or ≥2 (women)?
What is diabetic ketoacidosis, its clinical presentation, and recommended acute management?
What are the management recommendations for an adult with a blood pressure of 130/79 mmHg and no known cardiovascular disease, diabetes, chronic kidney disease, or target‑organ damage?
Could my elevated hemoglobin be caused by the hormonal changes associated with secondary adrenal insufficiency?
What are the signs and symptoms of acute and chronic pancreatitis?
How can I help a patient with cortisol‑induced central obesity lose weight?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question